Adicet Bio, Inc.
USD8.12
+0.23 (+2.92%)
CEO
Chen Schor
IPO Date
2018-01-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$8.09
Prev. Close
$7.89
Day Low
$7.91
Day High
$8.31
52W Low
$6.01
52W High
$17.44
Market Cap
$0.08B
Volume
0.04M
| 4,200 |
| $8.10 |
| 23 Jun 2026 | Grissinger Michael | director | A-Award | Acquired | 4,200 | $8.10 |
| 23 Jun 2026 | Sinclair Andrew | director | A-Award | Acquired | 4,200 | $8.10 |
| 23 Jun 2026 | Peng Katie | director | A-Award | Acquired | 4,200 | $8.10 |
| 23 Jun 2026 | Klickstein Lloyd | director | A-Award | Acquired | 4,200 | $8.10 |
| 23 Jun 2026 | Schor Chen | director, officer: President & CEO | A-Award | Acquired | 55,000 | $8.10 |
| 23 Jun 2026 | Aftab Blake | Chief Scientific Officer | A-Award | Acquired | 55,000 | $8.10 |
| 29 Apr 2026 | RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | J-Other | Disposed | 250,000 | $0.00 |
| 29 Apr 2026 | RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | J-Other | Acquired | 250,000 | $0.00 |